Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,738
datasets available to search
ShareScore release 0.9.0
Dataset results
2,738 results for “Multiple Sclerosis”
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT03073603. IPD Sharing: NO. Countries: 1. Publications: 3.
Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT00537082. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)
ClinicalTrials.gov study NCT00509145. IPD Sharing: Not stated. Countries: 24. Publications: 3.
Neuroprotection With Riluzole Patients With Early Multiple Sclerosis
ClinicalTrials.gov study NCT00501943. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients
ClinicalTrials.gov study NCT00871780. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Effect of MD1003 in Progressive Multiple Sclerosis (SPI2)
ClinicalTrials.gov study NCT02936037. IPD Sharing: NO. Countries: 13. Publications: 1.
A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compar
ClinicalTrials.gov study NCT01067521. IPD Sharing: Not stated. Countries: 17. Publications: 1.
Time Restricted Eating Outcomes in Multiple Sclerosis
ClinicalTrials.gov study NCT04389970. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Impact of Vitamin A Supplementation on Immune System in Multiple Sclerosis Patients
ClinicalTrials.gov study NCT01225289. IPD Sharing: Not stated. Countries: 1. Publications: 1.
High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
ClinicalTrials.gov study NCT00288626. IPD Sharing: YES. Countries: 1. Publications: 11.
The Effects of Tysabri Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis
ClinicalTrials.gov study NCT00536120. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00676715. IPD Sharing: Not stated. Countries: 18. Publications: 1.
A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT00883337. IPD Sharing: Not stated. Countries: 13. Publications: 2.
REbif FLEXible Dosing in Early Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT00404352. IPD Sharing: Not stated. Countries: 27. Publications: 5.
A Trial of Bile Acid Supplementation in Patients With Multiple Sclerosis
ClinicalTrials.gov study NCT03423121. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis
ClinicalTrials.gov study NCT01416181. IPD Sharing: Not stated. Countries: 17. Publications: 4.
A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients
ClinicalTrials.gov study NCT01964547. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00451451. IPD Sharing: Not stated. Countries: 28. Publications: 10.
Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis
ClinicalTrials.gov study NCT02040298. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS)
ClinicalTrials.gov study NCT02493049. IPD Sharing: NO. Countries: 1. Publications: 21.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.